Clinical Trial Update: Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a modified intraocular lens to reduce post-surgical eye inflammation in patients with uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts
• Uveitis

Drugs mentioned

• Modified Intraocular Lens

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Cataracts | Phase 2 | Status: COMPLETED